Vector-borne diseases (VBDs) represent a significant public health concern in India, contributing to a significant burden of morbidity and mortality. This article provides a comprehensive review of the prevalence and impact of VBDs in India, aiming to equip healthcare professionals with a deeper understanding of the current landscape.
India is endemic to several VBDs, including malaria, dengue, and chikungunya. According to the World Health Organization, India reported 6.7 million cases of malaria in 2018, representing 4% of the global total. Similarly, dengue cases have surged over the last decade, with over 101,000 cases reported in 2019. Chikungunya, though less prevalent, has seen sporadic outbreaks, causing significant public health concern.
VBDs exert a profound impact on India's public health system and economy. They strain healthcare resources, leading to increased healthcare costs and reduced productivity due to illness. The economic burden of malaria alone is estimated at $1.94 billion annually. Furthermore, the indirect costs associated with loss of productivity due to illness significantly affect India's economic growth.
Addressing VBDs in India requires overcoming several challenges, including inadequate vector control, diagnostic delays, and treatment gaps. The country's diverse topography and climate also contribute to the complexity of vector control. Moving forward, strengthening surveillance systems, improving diagnostic capabilities, and implementing effective vector control strategies are crucial to curbing the prevalence and impact of VBDs.
VBDs pose a significant threat to India's public health and economy. Understanding their prevalence and impact is crucial for healthcare professionals in formulating effective strategies for prevention and control. As we move forward, concerted efforts from all stakeholders are required to mitigate the burden of these diseases and safeguard public health.
1.
Race, Geography Linked to Gaps in Prostate Cancer Care
2.
Sports for girls are frequently abandoned due to uniform issues.
3.
According to the Lancet, having cancer and VTE at the same time increases mortality risk.
4.
Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer
5.
Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma
1.
Hematopoietic Clonal Competition in Blood Disorders
2.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
3.
Developmental Iron Biology Beyond Infancy: Mechanisms, Clinical Implications, and Emerging Directions
4.
Next-Generation Bone Marrow Harvest Technologies
5.
Strategic Applications in Hematology in Clinical Decision-Making
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding the Common Causes of Anemia
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation